Discontinuation report PANTO IV
| Report ID | 2969 |
| Drug Identification Number | 02239616 |
| Brand name | PANTO IV |
| Common or Proper name | Pantoprazole sodium |
| Company Name | TAKEDA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | PANTOPRAZOLE |
| Strength(s) | 40MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1 vial x 10 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-03-13 |
| Remaining supply date | 2017-03-13 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | There is no supply remaining. |
| Company comments | Unanticipated depletion of remaining stock by wholesaler due to generic drug shortage. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-03-15 | French | Compare |
| v1 | 2017-03-15 | English | Compare |
Showing 1 to 2 of 2